[Clinical evaluation of female pelvic tumors : Application fields of integrated PET/MRI].

J Grueneisen, L Umutlu
Author Information
  1. J Grueneisen: Institut für diagnostische und interventionelle Radiologie und Neuroradiologie, Universitätsklinikum Essen, Hufelandstr. 55, 45122, Essen, Deutschland. Johannes.grueneisen@uk-essen.de.
  2. L Umutlu: Institut für diagnostische und interventionelle Radiologie und Neuroradiologie, Universitätsklinikum Essen, Hufelandstr. 55, 45122, Essen, Deutschland.

Abstract

Integrated positron emission tomography (PET) and magnetic resonance imaging (MRI) scanning has recently become established in clinical imaging. Various studies have demonstrated the great potential of this new hybrid imaging procedure for applications in the field of oncology and the diagnostics of inflammatory processes. With initial studies demonstrating the feasibility and high diagnostic potential of PET/MRI comparable to PET-computed tomography (CT), the focus of future studies should be on the identification of application fields with a potential diagnostic benefit of PET/MRI over other established diagnostic tools. Both MRI and PET/CT are widely used in the diagnostic algorithms for malignancies of the female pelvis. A simultaneous acquisition of PET and MRI data within a single examination provides complementary information which can be used for a more comprehensive evaluation of the primary tumor as well as for whole body staging. Therefore, the aim of this article is to outline potential clinical applications of integrated PET/MRI for the diagnostic work-up of primary or recurrent gynecological neoplasms of the female pelvis.

Keywords

References

  1. Indian J Radiol Imaging. 2015 Apr-Jun;25(2):137-47 [PMID: 25969637]
  2. Ann Nucl Med. 2016 Feb;30(2):104-13 [PMID: 26546334]
  3. J Cancer Res Clin Oncol. 2009 Sep;135(9):1197-206 [PMID: 19288271]
  4. CMAJ. 2008 Mar 25;178(7):855-62 [PMID: 18362381]
  5. Eur J Radiol. 2009 Jul;71(1):164-74 [PMID: 18378417]
  6. AJR Am J Roentgenol. 2007 Jun;188(6):1577-87 [PMID: 17515380]
  7. Gynecol Oncol. 2013 Feb;128(2):397-404 [PMID: 23107613]
  8. Gynecol Oncol. 2003 Oct;91(1):59-66 [PMID: 14529663]
  9. AJR Am J Roentgenol. 2009 Mar;192(3):802-14 [PMID: 19234280]
  10. Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):56-65 [PMID: 25223420]
  11. Radiology. 2000 Jan;214(1):39-46 [PMID: 10644099]
  12. Cancer Sci. 2010 Jun;101(6):1471-9 [PMID: 20298252]
  13. Gynecol Oncol. 2013 Feb;128(2):300-8 [PMID: 23200916]
  14. Eur J Nucl Med Mol Imaging. 2015 Nov;42(12 ):1814-24 [PMID: 26199113]
  15. Eur Radiol. 2014 Apr;24(4):889-901 [PMID: 24322510]
  16. Eur J Radiol. 2012 May;81(5):1002-6 [PMID: 21349672]
  17. Gynecol Oncol. 2013 Nov;131(2):389-94 [PMID: 23994535]
  18. Eur Radiol. 2010 Dec;20(12):2773-80 [PMID: 20839002]
  19. Eur Radiol. 2015 Aug;25(8):2222-30 [PMID: 26017734]
  20. Eur J Nucl Med Mol Imaging. 2009 Mar;36(3):362-72 [PMID: 18931841]
  21. Radiology. 2005 Jul;236(1):85-94 [PMID: 15955864]
  22. Gynecol Oncol. 2005 Feb;96(2):301-6 [PMID: 15661212]
  23. CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90 [PMID: 21296855]
  24. Eur J Radiol. 2015 Nov;84(11):2097-102 [PMID: 26321491]
  25. Invest Radiol. 2014 Dec;49(12 ):808-15 [PMID: 25010207]
  26. Radiology. 1995 Dec;197(3):619-26 [PMID: 7480729]
  27. Eur Urol. 2016 Nov;70(5):829-836 [PMID: 26795686]
  28. Clin Cancer Res. 2014 Jul 1;20(13):3540-9 [PMID: 24963052]
  29. Nucl Med Commun. 2007 Aug;28(8):589-95 [PMID: 17625380]

MeSH Term

Biomarkers, Tumor
Diagnosis, Differential
Female
Genital Neoplasms, Female
Humans
Magnetic Resonance Imaging
Molecular Imaging
Multimodal Imaging
Pelvic Neoplasms
Positron-Emission Tomography
Radiopharmaceuticals
Tomography, X-Ray Computed

Chemicals

Biomarkers, Tumor
Radiopharmaceuticals

Word Cloud

Created with Highcharts 10.0.0diagnosticimagingpotentialPET/MRIMRIstudiesfemaleemissiontomographyPETresonanceestablishedclinicalapplicationsfieldsusedmalignanciespelvisevaluationprimarystagingintegratedpelvicIntegratedpositronmagneticscanningrecentlybecomeVariousdemonstratedgreatnewhybrid imagingprocedurefieldof oncologydiagnosticsinflammatoryprocessesinitialdemonstratingfeasibilityhighcomparablePET-computedCTfocusfutureidentificationapplicationbenefittoolsPET/CTwidelyalgorithmssimultaneousacquisitiondatawithinsingleexaminationprovidescomplementaryinformationcancomprehensivetumorwellwholebodyThereforeaimarticleoutlinework-uprecurrentgynecologicalneoplasms[Clinicaltumors:ApplicationPET/MRI]FemaleMultiparametricPositrontomography/magneticTherapyresponseassessmentTumor

Similar Articles

Cited By

No available data.